Story · Medicine & Biotech · Health Tech

Vivek Subbiah: Exploring AI-Based Prediction of Actionable Genomic Alterations From H&E-Stained Slides

1 outlet · first reported by OncoDaily on

Vivek Subbiah, Director of Early Phase Drug Development Program at NYU Langone Health, shared on LinkedIn: “Your Outlook email may not be working and your flight may be delayed so (OncoDaily)

Coverage, in order

  1. OncoDaily obscure study
    Vivek Subbiah: Exploring AI-Based Prediction of Actionable Genomic Alterations From H&E-Stained Slides

    Vivek Subbiah, Director of Early Phase Drug Development Program at NYU Langone Health, shared on LinkedIn: “Your Outlook email may not be working and your flight may be delayed so

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.